Owl Therapeutics

Curated by Signal

Developer of neurotherapeutics for or traumatic brain injury and associated cconditions

Life Sciences Technologyowltherapeutics.com

Overview

Developer of neurotherapeutics for or traumatic brain injury and associated cconditions. It offers a lead candidate OWL-1410 based on AI- and diagnostics to protect and restore neurons in patients with moderate to severe TBI.

Key facts

Founded: 2023
Headquarters: San Antonio, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Genetrace
Provider of listing and booking platform for a range of diagnostic tests
Life Sciences TechnologyAlameda, United States
GX Sciences
Online platform offering laboratory testing and genome analysis solutions for healthcare providers
Life Sciences TechnologyAustin, United States
FutraMed
Transcutaneous electrical cranial stimulator to reduce opioid dependence in chronic pain patients
Life Sciences TechnologyOrem, United States

About Owl Therapeutics

What does Owl Therapeutics do?

Developer of neurotherapeutics for or traumatic brain injury and associated cconditions.

Where is Owl Therapeutics headquartered?

Owl Therapeutics is headquartered in San Antonio, United States.

When was Owl Therapeutics founded?

Owl Therapeutics was founded in 2023.

Which sector is Owl Therapeutics in?

Owl Therapeutics operates in Life Sciences Technology.

Who are Owl Therapeutics's competitors?

Companies similar to Owl Therapeutics include Genetrace, GX Sciences, and FutraMed.